Janus Henderson Group PLC purchased a new position in Aveanna Healthcare Holdings Inc. (NASDAQ:AVAH – Free Report) in the fourth quarter, according to its most recent filing with the Securities & Exchange Commission. The firm purchased 23,600 shares of the company’s stock, valued at approximately $108,000.
A number of other hedge funds have also bought and sold shares of the company. KLP Kapitalforvaltning AS bought a new position in Aveanna Healthcare during the 4th quarter worth approximately $35,000. BNP Paribas Financial Markets acquired a new position in shares of Aveanna Healthcare in the 4th quarter valued at about $35,000. Tower Research Capital LLC TRC boosted its holdings in shares of Aveanna Healthcare by 662.2% in the 4th quarter. Tower Research Capital LLC TRC now owns 7,889 shares of the company’s stock valued at $36,000 after buying an additional 6,854 shares during the period. Catalyst Funds Management Pty Ltd grew its position in shares of Aveanna Healthcare by 321.4% during the 4th quarter. Catalyst Funds Management Pty Ltd now owns 11,800 shares of the company’s stock valued at $54,000 after buying an additional 9,000 shares during the last quarter. Finally, Sagespring Wealth Partners LLC acquired a new stake in Aveanna Healthcare during the fourth quarter worth about $57,000. 87.96% of the stock is currently owned by institutional investors and hedge funds.
Analyst Upgrades and Downgrades
A number of research analysts recently issued reports on the company. UBS Group boosted their price objective on Aveanna Healthcare from $4.50 to $5.00 and gave the company a “sell” rating in a research report on Friday, May 9th. Truist Financial reduced their price target on shares of Aveanna Healthcare from $6.00 to $5.50 and set a “hold” rating for the company in a report on Friday, April 11th.
Insider Transactions at Aveanna Healthcare
In other Aveanna Healthcare news, major shareholder Robert M. Williams, Jr. sold 91,061 shares of the stock in a transaction on Thursday, May 8th. The stock was sold at an average price of $5.84, for a total transaction of $531,796.24. Following the completion of the transaction, the insider now directly owns 545,330 shares of the company’s stock, valued at approximately $3,184,727.20. This trade represents a 14.31% decrease in their position. The sale was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Also, major shareholder J.H. Whitney Equity Partners V sold 1,560,700 shares of Aveanna Healthcare stock in a transaction on Monday, May 19th. The shares were sold at an average price of $5.36, for a total value of $8,365,352.00. Following the transaction, the insider now owns 29,640,756 shares in the company, valued at approximately $158,874,452.16. This trade represents a 5.00% decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last quarter, insiders sold 4,887,612 shares of company stock valued at $26,269,057. 7.80% of the stock is currently owned by corporate insiders.
Aveanna Healthcare Price Performance
Shares of AVAH stock opened at $5.32 on Monday. The business has a 50 day simple moving average of $5.09 and a 200 day simple moving average of $4.95. The firm has a market capitalization of $1.04 billion, a price-to-earnings ratio of -15.65 and a beta of 2.01. Aveanna Healthcare Holdings Inc. has a 12-month low of $2.32 and a 12-month high of $6.19.
About Aveanna Healthcare
Aveanna Healthcare Holdings Inc, a diversified home care platform company, provides pediatric and adult healthcare services in the United States. Its patient-centered care delivery platform allows patients to remain in their homes and minimizes the overutilization of high-cost care settings, such as hospitals or skilled nursing facilities.
Further Reading
- Five stocks we like better than Aveanna Healthcare
- How to Calculate Retirement Income: MarketBeat’s Calculator
- This Market Sell-Off Might Trigger a Value Rotation Into Pepsi
- How to Buy Cheap Stocks Step by Step
- Alphabet Stock Lags—But Waymo May Be Its Hidden Driver
- Why Invest in High-Yield Dividend Stocks?
- Trade Desk Silences Critics; Recovery Looks Poised to Continue
Receive News & Ratings for Aveanna Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aveanna Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.